CliniSys has launched a new laboratory information management system for genomic hubs in the UK.
The company has brought GLIMS Genomics to the UK from Europe, where it is being deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months.
GLIMS Genomics has been designed to support the effective management of genomic laboratories, with the NHS now delivering a national Genomic Medicine Service for England through seven Genomic Laboratory Hubs.
These aim to deliver a comprehensive, standardised testing service for English hospitals as genomic testing starts to become a routine part of clinical practice.
Emma Huntridge, business development director at CliniSys, said: “Genomic medicine is no longer the preserve of a few, small, research groups. It is on the cusp of being an established diagnostic tool for some cohorts of patients.
“To support this development, genomic laboratories need to change; and the technology they use will need to change with them.
“They need to move away from the labour intensive, disjointed spreadsheet or paper-based management of samples, to a more automated, streamlined approach so they can increase their sample throughput, adopt standardised workflows and seamlessly deliver results to clinicians via integration
“At CliniSys, we believe now is the time for them to benefit from all the advantages that a bespoke modern LIMS can provide, and GLIMS Genomics will enable them to do that through its fully customisable features, workflows and interfaces.”
CliniSys Group is an international organisation made up of two component companies. MIPS specialises in clinical laboratory information management solutions, while CliniSys provides LIMS to 50% of NHS trusts and 30 pathology networks.
GLIMS Genomics was developed by a dedicated team within MIPS and was introduced to the European market last year.
Poitiers University Hospital in south west France is in the late stages of deploying the new system.
Huntridge added: “What is known as precision medicine is sending ripples of excitement through the clinical community and holds out enormous potential for patients. However, it depends on the effective management and reporting of tests, and their integration into the patient history.
“That is what GLIMS Genomics is built to do, and with its launch in the UK, we very much look forward to supporting genomics laboratories as they prepare for this exciting future.”
Sign up to our newsletter